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ABSTRACTSResults:103patientswere surveyedand65have responded.14patients(22%)
were treated conservatively, 23(35%) had radiological intervention, 4(6%) had
combined radiological and surgical treatment, 9(14%) underwent bypass
surgery and 15(23%) had amajor amputation. Only 13 patients(20%) reported
improvement in their daily activity following the treatment and in 33(50.8%)
their activity remained unchanged. Overall, 55 patients(85%) were satisﬁed
with treatment they had received. When comparing non-amputees to am-
putees, there was no statistically signiﬁcant difference between the satis-
faction scores in the two groups(84% vs 87%; p 0.6714).
Conclusions: Majority of the patients were satisﬁed with the treatment.
Therefore pain relief, not an improvement in functional status, seems to be
a major feature contributing to patient satisfaction following the CLI
treatment and amputees are not less satisﬁed than non-amputees.
0782: TEN YEAR EXPERIENCE OF MANAGING RAAA IN A DGH
Adnan Qureshi, Carolyn Thomas, Sarah Shahzad, Salem Al-Hamali,
Mohamed Elshaer. Kettering General Hospital NHs Foundation Trust,
Kettering, UK.
The relative merits of repairing abdominal aortic aneurysms (AAA) in
district hospital have long been debated. This article addresses the issue of
outcome of open emergency surgery for RAAA in a local district general
Hospital. At least one-half of all AAA repairs in the UK are carried out in
district general hospitals.
Methods: Retrospective 10 year data fromMarch 2002 to March 2012 was
collected using hospital electronic system; emergency repairs of RAAA
were analyzed against mortality.
Results: In ten Year 166 patients were admitted with diagnosis of RAAA.
M:F was 4:1,avarge age of 77 years. Average size of the aneurysm was 8.0
cm. 42%(n¼71) of the patient had some form of imagining on admission.
Out 166 only 104 were operated with Survival rate of 62 %(n¼63). 36(21%)
were not suitable for operation and 26(15%) were shifted to other trusts.
Conclusion:Mortality rate of 60-90% in England and Wales been reported
due to RAAA. Our data suggest survival rate of 60% which is comparable to
any vascular unit. With the reforms of vascular units with dedicated
vascular services RAAAmortality should go down further. Future impact of
these reforms will be interesting to monitor.
0799: VACUUM ASSISTED CLOSURE THERAPY FOR INFECTED GROIN
WOUNDS FOLLOWING VASCULAR SURGERY
Claire Goatman 1, George A. Antoniou 2, J. Vincent Smyth 1, David Murray 1.
1Department of Vascular and Endovascular Surgery, Manchester Royal
Inﬁrmary, Central Manchester University Hospitals Foundation Trust,
Manchester, UK; 2Department of Vascular Surgery, Red Cross Hospital, Athens,
Greece.
Aims: Vacuum assisted closure (VAC) therapy is increasingly used for
management of wound infection. We assessed outcomes for infected groin
wounds following vascular surgery.
Methods: A case series of 10 patients treated with VAC therapy for groin
wound infections following vascular surgical procedures performed May
2010- December 2012 in a tertiary vascular unit. VAC therapy was
continuous at 125mmHg, unless graft exposure present.
Results: Mean patient age was 70.8 years. Infection occurred mean 43.9
(median 12) days post-operatively. Szilagyi score was 2 in 70%, score 3 in
30%. Graft exposure was present in 20%. Mean VAC treatment length was
22.6 days, with no incidence of bleeding following application. Complete
wound healing was achieved in 80%, recorded mean time to healing 95
days. Mean follow-upwas 10.6months; 3 patients remain under follow-up
with one in-patient. One patient required femoral artery ligation with
subsequent limb loss. There was one late graft explantation with re-do
procedure. Of patients who had prosthetic material in the groin, 67% had
favourable outcome. No recorded mortality.
Conclusions: VAC therapy can be a safe and effective treatment modality
for treating post-operative groin wound infection in the presence of
arterial reconstruction and grafts. Graft explantation is not mandatory.
0839: THE ANGIOSOME MODEL AS AN EFFECTIVE PARADIGM TO
IMPROVE CLINICAL OUTCOMES OF INFRA-POPLITEAL
REVASCULARIZATION
Claire Goatman 1, George A. Antoniou 2, Stavros A. Antoniou 3,
Ganesh Kuhan 1, George S. Georgiadis 4, David Murray 1. 1Department ofVascular and Endovascular Surgery, Manchester Royal Inﬁrmary, Central
Manchester University Hospitals Foundation Trust, Manchester, UK;
2Department of Vascular Surgery, Red Cross Hospital, Athens, Greece;
3Department of Surgery, University Hospital of Heraklion, University of Crete,
Heraklion, Greece; 4Department of Vascular and Endovascular Surgery,
Democritus University of Thrace, Alexandroupolis, Greece.
Aim: The angiosome concept is based on the selective approach for revas-
cularization of the ischaemic foot, relying on the knowledge of the anatomy
of distinct vascular territories (angiosomes). We set out to conduct a sys-
tematic literature review and pooled analysis of outcomes of infra-popliteal
arterial reconstruction based on the angiosome model of perfusion.
Methods: PubMed was searched for studies comparing outcomes of direct
(DR) and indirect (IR) revascularization of the speciﬁc anatomic areawhere
the ischaemic ulcer was located. Identiﬁed outcomes were transformed
into a dichotomous outcome for speciﬁc time periods, and overall effect
sizes were calculated using ﬁxed/ random effects models.
Results: Seven studies reporting on 1252 limbs (DR, 687; IR, 565) were
identiﬁed. Wound healing rate was signiﬁcantly higher in the DR group
(odds ratio 2.09, 95% conﬁdence interval 1.51-2.91, p < 0.001). Limb
salvage was also improved in the DR group at 6 and 12 months following
revascularization. Even though amputation-free survival rates were
signiﬁcantly higher in DR limbs at 12months, overall survival did not differ
between the groups at 6 and 12 months of treatment.
Conclusions: The target vessel directly feeding the ischaemic angiosome
should be considered when planning infra-popliteal revascularization for
critical limb ischaemia.
0887: THE ADEQUACY OF ANTICOAGULATION WITH IV UNFRACTIO-
NATED HEPARIN
Zymrije Syla, Gareth Harrison, Leith Williams. Wirral University Teaching
Hospitals NHS Trust, Wirral, UK.
Aim: Heparin is commonly prescribed as an IV unfractionated infusion for
venous thromboembolism, patients with mechanical cardiac valves and
atrial ﬁbrillation. Our aimwas to determine the proportion of time that the
APTT was within therapeutic range.
Method: We retrospectively reviewed all adult patients who had IV hep-
arin infusion over an 11 month period. We recorded the duration, APTT
results, admitting speciality and indication.
Results: A total of 88 patients were included (52 male) with a median age
(range) of 66 years (24 e 93). The median duration (range) of treatment
with heparin was 4 days (1 - 15). The APTT was within therapeutic range
only 22% of the time, 45% of the time it was sub therapeutic and 33% of the
time over therapeutic. There was no signiﬁcant variation between
admission specialties (medicine, general and vascular surgery) or
indication.
Conclusion: We have demonstrated that patients on unfractionated
heparin infusion do not achieve a desirable APTT 78% of the time. This
suggests that they carry an additional risk of developing a thromboembolic
event, despite attempted anticoagulation therapy. We recommend that
subcutaneous low molecular weight heparin may be safer and more
therapeutic and this is the subject of a future study.
0944: MID-TERM FOLLOW UP OF THE FASCIAL CLOSURE TECHNIQUE
FOLLOWING EVAR
David Lyons Ewing, G.J. Harrison, D. Thavarajan, J.A. Brennan,
S.R. Vallabhaneni, R.G. McWilliams, Robert Fisher. Royal Liverpool and
Broadgreen University Teaching Hospital, Liverpool, UK.
Aim: Fascial closure is a minimally invasive closure technique following
percutaneous access for EVAR. The aim of this study was to identify the
mid-term risk of pseudoaneurysm formation, of which there is an inherent
risk, following fascial closure.
Method: Patient, operative and follow up data for prospectively identiﬁed
fascial closure candidates was recorded on an EVAR database. Recognised
follow-up protocols included Duplex and/or CT angiography, which
imaged the femoral vessels. Primary outcomemeasures were the presence
of a pseudoaneurysm and their secondary intervention. Secondary out-
comes were their size and resolution.
Results: Between Feb 2008 and March 2012 there were 159 attempted
facial closures, 144 of which were successful (91%) in 87 patients that
underwent EVAR. Eight patients having successful fascial closure
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ABSTRACTSdeveloped a total of 9 pseudoaneurysms (6.3%:one bilateral), none of
which required secondary intervention. Median pseudoaneurysm diam-
eter was 8.4mm at diagnosis. Median follow up was 24 months. Three
pseudoaneurysms had resolved at one year and a fourth by 2 years. Four
patients died at a median of 15 months; none due to pseudoaneurysms.
Conclusion: There is a low rate of pseudoaneurysm formation after fascial
closure and no clinical impact in the mid-term. Fascial closure remains a
safe and minimally invasive option.
0963: OUTCOMES FOLLOWING ARTERIAL ANGIOPLASTY IN SYMPTOM-
ATIC INFRAPOPLITEAL DISEASE: A SYSTEMATIC REVIEW OF THE
LITERATURE
James Glasbey 2, David Bosanquet 1, Michael Lewis 1. 1Department of
Surgery, Royal Glamorgan Hospital, Llantrisant, South Wales, UK; 2Cardiff
University School of Medicine, Cardiff, UK.
Aim: Despite a wealth of research into percutaneous intervention for
arterial disease, the role of angioplasty in treating symptomatic infrapo-
pliteal disease remains undeﬁned. Whilst historically, surgical revascu-
larisation has been the cornerstone of its management, angioplasty is
recommended for limb salvage where open surgery is contra-indicated.
Should non-inferiority be demonstrated, increasing use of endovascular
techniques may reduce the morbidity associated with open surgery. This
study's aims are to summarise reported outcomes in endovascular crural
disease management.
Methods: A systematic review of the Cochrane Library, OVID/Medline and
Pubmedwas performed from 1990 to December 2012. Keywords included:
‘infrapopliteal', ‘angioplasty', ‘stenting', ‘outcomes'. Related article func-
tions were also searched. Clinical and technical success parameters were
recorded.
Results: No level I evidence exists as to the superiority of bypass over
percutaneous transluminal angioplasty (PTA). Two randomised controlled
trials (RCT) demonstrated non-superiority of bare-metal stenting over PTA,
whilst initial reports from three RCTs suggest a role for sirolimus/ever-
olimus/paclitaxel-eluting stents in improving clinical outcomes.
Conclusions: A level I, intention-to-treat study of angioplasty+/-stenting
vs. bypass will be required before the precise role of infrapopliteal an-
gioplasty can be deﬁned. Drug-eluting stents have shown early promise
and may thus facilitate further paradigm shift away from more morbid
surgical management techniques.
1009: ROLE OF ANGIOGRAPHIC RUN OFF SCORE AS A TOOL TO PREDICT
LONG TERM OUTCOME FOLLOWING LOWER LIMB BYPASS SURGERY
Manish George, Rosie Cadwallader, Jonathan Ghosh. Vascular Surgery
Department, University Hospital South Manchester, Manchester, UK.
Objectives: To evaluate the role of peripheral artery run-off scoring as
predicted by the SVS/ISCVS system in predicting the fate of infrainguinal
bypass grafts.
Methods: A retrospective cohort study of all patients enrolled in a Duplex-
based lower limb graft surveillance programme since January 2007 at a
tertiary vascular centre. Outﬂow vessels were graded according to the SVS/
ISCVS Ad Hoc scoring system based on preoperative magnetic resonance
angiography. All candidates were followed up for re-intervention or graft
occlusion until January 2012 or discharge from the surveillance
programme.
Results: 178 patients underwent follow up after infrainguinal bypass. The
primary indication for surgery was: critical limb ischaemia (60%); aneu-
rysm (28%); claudication (10%), and trauma (2%). The median follow up
timewas 28 months (range, 3-56 months). Primary patency rate was 79.2%
at the completion of follow up. Secondary patency rate was achieved in an
additional 14.1%. Twelve subjects had graft failure of whom 8 required
amputation. Mean run off score in the re-intervention group was 6.0, 6.5 in
those resulting in amputation compared to 5.5 in those with primary
patency. ANOVA p-value 0.218.
Conclusions: Preoperative run off score did not predict re-intervention or
mid term graft patency.
1032: ULTRASOUND GUIDED FOAM SCLEROTHERAPY (UGFS) FOR
ACTIVE VENOUS ULCERATION e A 5-YEAR COHORT
Andrei Tanase, Gagandeep Grover, Alan Elstone, Simon Ashley. Derriford
Hospital, Department of Vascular Surgery, Plymouth, UK.Aim: Ultrasound guided foam sclerotherapy (UGFS) for treatment of CVU
(chronic venous ulceration) has demonstrated favourable results in pre-
liminary studies. This study analyses healing and recurrence rates in
CEAP6 ulcers treated with UGFS.
Method: Between 2007 and 2012, 60 patients (63 legs) underwent UGFS
with sodium tetradecyl-sulphate(STS) for CEAP6 ulcers. All patients were
followed up at 2.5 months both clinically and venous duplex was per-
formed before and after treatment. We analysed a prospectively collected
database and calculated venous occlusion rates, 12 month healing and
recurrence rates.
Results: 63 legs, 43 primary; 20 recurrent. Median time ulcer active 15
months (IQR 9 - 24); range 5 months e 17 years. At a median follow-up 2.5
months 57(90.5%) achieved full occlusion; 3(4.8%) short segment occlu-
sion, 4(4.8%) failed to occlude. 13 required repeat treatment. 2 pts reported
thrombophlebitis. 10 patients excluded from outcome analysis. 37(70%)
healed at a median time of 4months; 13(24.5%) at 3months, 24(45.3%) at
6months, 30(56.6%) at 12months. 14(28.3%) signiﬁcantly reduced and
healing; 7 almost healed and discharged; 12 month recurrence rate
2(3.7%).
Conclusions: USFS is a feasible component of the leg ulcer service and a
safe and effective means of securing superﬁcial vein occlusion as an
alternative to surgery.
1049: GRAFT INFECTION FOLLOWING VASCULAR SURGERY: INCIDENCE,
MANAGEMENT APPROACH AND OUTCOMES
Pavlos Iosiﬁdis, Mohamed Barakat, Jessica Veitch, Anoushka Kansara,
Carys Bather, Sameh Dimitri, Maher Hammish. Countess of Chester
Hospital, Chester, UK.
Aim: The aim of this study is to determine the incidence of graft infection
in our vascular unit, our management approach and outcome.
Methods: A retrospective study from case notes and a prospective data-
base of 168 patients who underwent vascular surgery with graft insertion
from January 2008 to December 2011. Patient demographic, type and site
of surgery, CEPOD grade of surgery, antibiotic prophylaxis, onset of graft
infection and treatment options were included in the data.
Results: 168 patients were included in our study. Carotid endarterectomy
(CEA) was the most performed procedure (48.8%) followed by femoral
bypass/endarterectomy (32.8%) and aortic surgery (18.4%). The majority of
the operations were elective 78% and 22 % were emergency. Cefuroxime,
Teicoplanin and Gentamicin were prophylactic antibiotics of choice in our
unit. Only 4 (2.38%) cases of graft infection were identiﬁed (2 CEA, 1 Aorto
by-Femoral bypass, 1 Femoro- popliteal bypass). All these patients un-
derwent removal of the graft and reconstructive vascular surgery. One
patient had an amputation as consequence of graft infection despite
reconstructive surgery. There was no mortality.
Conclusion: Our graft infection rate is very low with triple prophylactic
antibiotics. Graft removal and reconstructive vascular surgery remain the
standard management approach.
1062: SYNCHRONOUS CAROTID ENDARTERECTOMY (CEA) AND CARDIAC
SURGERY (CS): A SINGLE CENTRE EXPERIENCE OVER THIRTEEN YEARS
Thomas Hubbard, Marc Bailey, Kathryn Grifﬁn, Julian Scott. Leeds Vascular
Institute, Leeds, UK.
Introduction: This study reports rationale for and outcome of synchro-
nous carotid endarterectomy (CEA) and cardiac surgery (CS) over thirteen
years in our institution.
Methods: Patients undergoing CEA and CS between 1998-2011 were
identiﬁed, casenotes retrieved and retrospectively reviewed. Patients were
divided into; previously neurologically symptomatic (CEAS) and asymp-
tomatic (CEAA) and followed up to present day.
Results: 20,320 patients underwent CS during the study period; 64 had
CEA. 14 were excluded due to casenote loss or destruction. Twenty seven
patients (54%) formed the CEAS group (12 completed strokes, 15 TIA)
with average EuroScore of 8.23; 23 formed the CEAA group with average
EuroScore of 8.33. The rationale for Carotid Doppler Ultrasound in CEAA
:carotid bruit in 10 (20%), routine work-up in 11 (22%), re-evaluation of
existing carotid lesion in 2 (4%). 80% of CEA were for high grade (70-99%)
stenosis, 10 patients (20%) had bilateral disease. Thirty day stroke/death
rate was 14% (12% CEAS vs. 16% CEAA, p¼0.3). The only predictor of 30
